92 related articles for article (PubMed ID: 25488568)
21. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911
[TBL] [Abstract][Full Text] [Related]
22. Risk factors associated with mortality and morbidity after elective splenectomy.
Aksnes J; Abdelnoor M; Mathisen O
Eur J Surg; 1995 Apr; 161(4):253-8. PubMed ID: 7612767
[TBL] [Abstract][Full Text] [Related]
23. Splenectomy in hematologic malignancy.
Garrison RN; McCoy M; Winkler C; Yam L; Fry DE
Am Surg; 1984 Aug; 50(8):428-32. PubMed ID: 6465689
[TBL] [Abstract][Full Text] [Related]
24. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
[TBL] [Abstract][Full Text] [Related]
25. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
[TBL] [Abstract][Full Text] [Related]
27. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
Brenner B; Nagler A; Tatarsky I; Hashmonai M
Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
[TBL] [Abstract][Full Text] [Related]
28. [Results of splenectomy with polychemotherapy in the treatment of 15 chronic myeloid leukemia patients].
Mendeleev IM; Berliner GB; Miasnikov AA; Polezheav IuN
Ter Arkh; 1986; 58(9):84-8. PubMed ID: 3466393
[TBL] [Abstract][Full Text] [Related]
29. Splenectomy in early chronic myeloid leukemia.
Castrini G; Pappalardo G
Int Surg; 1979; 64(6):21-6. PubMed ID: 299444
[TBL] [Abstract][Full Text] [Related]
30. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
31. Indications and complications of splenectomy for children with sickle cell disease.
Al-Salem AH
J Pediatr Surg; 2006 Nov; 41(11):1909-15. PubMed ID: 17101369
[TBL] [Abstract][Full Text] [Related]
32. [Spleen irradiation and splenectomy for treatment of hypersplenism in chronic myeloid leukemia and chronic lymphatic leukemia (author's transl)].
Stolzenbach G; Franke HD; Montz R; Schulze PJ
Strahlentherapie; 1979 Feb; 155(2):82-6. PubMed ID: 284643
[TBL] [Abstract][Full Text] [Related]
33. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
van Besien K; Artz A; Smith S; Cao D; Rich S; Godley L; Jones D; Del Cerro P; Bennett D; Casey B; Odenike O; Thirman M; Daugherty C; Wickrema A; Zimmerman T; Larson RA; Stock W
J Clin Oncol; 2005 Aug; 23(24):5728-38. PubMed ID: 16009946
[TBL] [Abstract][Full Text] [Related]
34. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
35. Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
Lim ZY; Pearce L; Ho AY; Barber L; Ingram W; Usai M; Tobal K; Devereux S; Pagliuca A; Mufti GJ
Br J Haematol; 2007 Aug; 138(4):517-26. PubMed ID: 17608767
[TBL] [Abstract][Full Text] [Related]
36. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
[TBL] [Abstract][Full Text] [Related]
37. Massive splenomegaly.
Johnson HA; Deterling RA
Surg Gynecol Obstet; 1989 Feb; 168(2):131-7. PubMed ID: 2911790
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: role of splenectomy.
Zhang Y; Yan L; Wen T; Li B; Zhao J; Chen Z; Wang W; Xu M; Yang J; Wei Y; Ma Y; Jiang L
J Surg Res; 2012 Nov; 178(1):478-86. PubMed ID: 22483806
[TBL] [Abstract][Full Text] [Related]
39. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.
Mohty M; Bilger K; Jourdan E; Kuentz M; Michallet M; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Sadoun A; Ifrah N; Guyotat D; Faucher C; Fegueux N; Reiffers J; Maraninchi D; Blaise D
Leukemia; 2003 May; 17(5):869-75. PubMed ID: 12750699
[TBL] [Abstract][Full Text] [Related]
40. Splenectomy for massive splenomegaly.
Coon WW
Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]